In in vitro and in vivo models of human pancreatic and gastric cancer, NKG2D was found to determine the recognition of cancer stem cells (CSCs) by NK cells, depending on the expression of CD133 and CD24 [54,55]. Here, KLRK1 is linked to cancer.